The Dow Jones Industrial Average (DJIA) is recovering today after the index suffered throughout the week alongside a stock market selloff. That selloff came after President Donald Trump further ...

The Dow Jones Industrial Average (DJIA) continues to drop today as an escalating trade war occupies investors’ minds. The big news affecting the index on Tuesday is President Donald Trump ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Perhaps the most popular stock index in the world, the Dow Jones Industrial Average tracks the performance of 30 prominent stocks that investors trade most often. Are futures riskier than options?

The Dow Jones Industrial Average closed with a loss of 890 points Monday, falling 2.1 percent. The Nasdaq composite closed with a loss of 4 percent, and the S&P 500 index closed down 2.7 percent.

Purple Innovation Inc. $0.90 0.24 35.63% ...

The Dow Jones 30 is an index of the 30 most prominent companies traded in the U.S. Yes, investors can buy Dow Jones 30 futures to gain exposure to massively expensive stocks across a broad range ...

The Dow Jones tested fresh lows on Tuesday but remained stuck near 43,500. Investor confidence was dealt a blow after consumer confidence slipped further. Signs of a widespread economic slowdown ...

Wall Street futures largely pointed sideways pre-bell Thursday as traders awaited another national inflation report, and weighed the evolving trade policies of the Trump administration. In the futures ...

NEW YORK, Feb. 24, 2025 /PRNewswire/ -- Dow Jones today announced it has agreed to acquire Dragonfly Intelligence, a geopolitical and security intelligence provider, and Oxford Analytica ...

The Dow Jones fell 1.6% to 43,4500 on Friday. US PMIs came in mixed, consumer sentiment fell, inflation expectations accelerated. UnitedHealth is reported to be under investigation by the US ...

Beam Therapeutics shares were 14% lower, at $24.60, after the company priced an underwritten offering with proceeds of $500 million. The biotechnology company said it is offering 16.2 million shares ...